ELAYNA DOWD: Open Payments
NPI 1386308443 · OLEAN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$967 in 54 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $112 · 2025 $967
Food & beverage: $967
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 19 | $287 |
| Lilly USA, LLC | 8 | $159 |
| Novo Nordisk Inc | 5 | $105 |
| Viatris Specialty LLC | 4 | $64 |
| Merck Sharp & Dohme LLC | 3 | $62 |
| Exact Sciences Corporation | 3 | $61 |
| Paratek Pharmaceuticals, Inc. | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Dexcom, Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
Products named: GEMTESA, Ozempic, JARDIANCE, YUPELRI, GARDASIL 9, Cologuard Collection Kit, MOUNJARO, NUZYRA.
Industry payments across NY — which companies pay providers there.
